UT Health Science Center’s Liza Makowski Leads Study on Long-Term Cancer Risks of Popular GLP-1 Obesity Drugs
As the obesity epidemic continues to affect the U.S. healthcare system, a new commentary discusses GLP-1 drugs, including Ozempic, Wegovy, and Zepbound, which have become widely used in obesity treatment.